Evidence map›Paper›PMID 37252543›Full record

ArticleCureus2023

The Foggy Lungs: A Case Report on Pulmonary Alveolar Proteinosis.

Gokul Paidi, Jugroop S Brar, Andrea S Vizcaino Duran, Jose Benero-Fossatti, Anhad Brar, Farrah P Aziz Greye

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

Gokul PaidiPulmonary and Critical Care Medicine, Arizona Lung, Sleep and Valley Fever Institute, Surprise, USA.
Jugroop S BrarPulmonary and Critical Care Medicine, Arizona Lung, Sleep and Valley Fever Institute, Surprise, USA.
Andrea S Vizcaino DuranMedical Surgery, Universidad Autonoma de Guadalajara, Guadalajara, MEX.
Jose Benero-FossattiGeneral Medicine, Universidad Autonoma de Guadalajara, Guadalajara, MEX.
Anhad BrarPulmonary and Critical Care Medicine, Arizona Lung, Sleep and Valley Fever Institute, Surprise, USA.
Farrah P Aziz GreyePulmonary and Critical Care Medicine, Arizona Lung, Sleep and Valley Fever Institute, Surprise, USA.
Lung Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare interstitial lung disease characterized by macrophage dysfunction leading to the accumulation of surfactant in the alveoli and bronchiolar spaces, leading to impaired gas exchange and severe hypoxemia. The underlying mechanisms of PAP are not fully understood, but it is believed to involve impaired clearance of surfactant and abnormal immune responses. Diagnosis of PAP typically involves imaging studies and bronchoscopy, and treatment options include whole-lung lavage, pharmacotherapy, and lung transplantation. We report PAP in a 56-year-old female who worked in a dental office and had no prior diagnosis of lung disease.

Indexed as

alveoligranulocyte stimulating factorlavagemachrophagepulmonary alveolar proteinosis

Identifiers

PMID37252543
PMCPMC10215024
OpenAlexW4367050075

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.